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Abstract
Background. Patients with Parkinson’s disease (PD) are encouraged to stay active to maintain their mobility. Ambulatory
activity monitoring (AM) provides an objective way to determine type and amount of gait-related daily activities.
Objective. To investigate the effects of a home cueing training program on functional walking activity in PD. Methods. In a
single-blind, randomized crossover trial, PD patients allocated to early intervention received cueing training for 3 weeks,
whereas the late intervention group received training in the following 3 weeks. Training was applied at home, using a
prototype cueing device. AM was applied at baseline, 3, 6, and 12 weeks in the patient’s home, to record body
movements. Postures and motions were classified as percentage of total time spent on (a) static activity, further specified
as % sitting and % standing, and (b) % dynamic activity, further specified as % walking, % walking periods exceeding
5 seconds (W>5s) and 10 seconds (W> 1 0s). Random coefficient analysis was applied. Results. A total of 153 patients
participated in this trial. Significant improvements were found for dynamic activity (b = 4.46; P < .01), static
activity (b = -3.34; P < .01), walking (b = 4.23; P < .01), W>5s (b = 2.63; P < .05), and W> 1 0s (b = 2.90; P <
.01). All intervention effects declined significantly at 6 weeks follow- up. Conclusion. Cueing training in PD
patients’ own home significantly improves the amount of walking as recorded by AM. Treatment effects reduced after the
intervention period, pointing to the need for permanent cueing devices and follow-up cueing training.
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Introduction
Parkinson’s disease (PD) is one of the most common neurological disorders in elderly people.1 Between the age of 55 and 85
years, 4.2% of all women and 6.1% of all men develop PD.2 The major motor symptoms in PD are tremor, rigidity,
bradykinesia, and postural instability, resulting in problems with gait, balance, transfers, and posture.3 These problems can lead
to reduced mobility and decreased levels of physical activity, which in turn can cause increased dependency and social
isolation and thereby reduce quality of life.4 It is therefore important to encourage patients to maintain their mobility and to
stay active, for example, by referring them to physical training programs.5-7
These physical exercise programs include use of rhythmic cues. Cueing can be defined as using external temporal or
spatial stimuli to facilitate movement (gait) initiation and continuation.8 Unfortunately, evidence-based knowledge about
effects of cueing in PD is limited. Best-evidence synthesis of 24 studies, up to 2002, showed only 1 high- quality study
specifically focused on the effects of auditory rhythmical cueing.9 Studies claim positive effects of cueing on gait speed of
patients with PD; however, it was unclear whether positive effects identified can be generalized to
improved activities of daily living in patients’ own home setting and reduced frequency of falls in the community.10 In
addition, the sustainability of a cueing training program remains uncertain.10 A recent review on cueing suggests that cueing
can have an immediate and powerful effect on gait in PD.10 The studies included in this review, however, suffered from lack
of methodological quality and were mostly executed in laboratory situations. The need for studies with high
methodological quality stimulated the initiation of a randomized controlled trial with the acronym RESCUE
(REhabilitation in Parkinson’s disease Strategies for CUEing). It was shown that a cueing program using auditory, visual,
and tactile cues improved posture and gait scores, gait speed, step length, and timed balance tests in patients with PD.8 In
addition, secure mobility during functional activities was improved, and freezers showed a reduction in the severity of
freezing. These RESCUE trial results are single, cross-sectional snapshots of the capacity of the PD patients and were
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obtained in the on-phase of medication. Results from such clinical testing are assumed to reflect patients’ “real-world”
activities related to gait. However, test performance achieved in optimally medicated situations, often when patients are
not fatigued, combined with patients’ desire to perform optimally, may overestimate their actual performance.
In contrast, ambulatory activity monitoring (AM) provides an objective way to determine type and amount of gait-
related activities for up to 72 hours.11 Recent advances in technology have resulted in the development of AMs capable of
assessing a number of functional abilities, such as (a) the length of time spent in body positions (including static positions
such as supine, side lying, prone, sitting, and standing), (b) the number of transitions between these positions, (c) the length
of time spent in dynamic activities such as walking and cycling, (d) the number of walking periods, and (e) stride
frequency.12 Therefore, AM could provide more “real-world” information about patients’ behavior during a day,
irrespective of daily fluctuations in on-phase and off-phase. AM is a reliable and valid method for determining walking
activity in PD patients.12,13 In a recent reliability study, high intraclass correlation coefficients (ICCs) ranging from .81 to .96 were
found for monitoring walking in patients with PD.12 However, the test–retest reliability coefficients between 3 consecutive
measurements were relatively lower for the categories transfers (ICC = .56), sitting (ICC = .65), and standing (ICC = .75)
when compared with walking (ICC = .92).12 In addition, the RESCUE trial is a collaboration between 3 European countries
in which day-time AM is used. Both findings legitimate reliability testing between the 3 observers in terms of absolute
agreement in the RESCUE project.
The objective of the present study is to investigate the effect of cueing training on the amount of physical activity,
specifically walking, in patients with PD, when monitored in their own home environment. We hypothesized that cueing
therapy for 3 weeks would specifically increase the dynamic activities such as walking and accordingly decrease the static
activities such as sitting and lying, when compared with no cueing training. A second aim of this study was to investigate
the reliability of AM over a 3-week interval.
Methods
For the RESCUE trial, 153 patients were recruited in 3 different countries: 48 patients were recruited at Northumbria
University, Newcastle upon Tyne (UK); 51 patients were recruited at the Katholieke Universiteit Leuven (Belgium); and 54
patients were recruited at the VU University Medical Center, Amsterdam (The Netherlands). Main eligibility criteria were (a)
idiopathic PD, (b) Hoehn and Yahr15 stage II to IV, (c) showing mild to severe gait disturbances, (d) stable medication usage, (e)
age 18 to 80 years, and (f) absence of cognitive impairment and disorders interfering with participation in cueing therapy. A
more detailed description of all eligibility criteria can be found in Nieuwboer et al.8 All patients gave written informed
consent. The study was approved by all medical ethics committees of the participating centers.
Design and Procedures
The RESCUE trial was a single-blind, randomized clinical trial with a crossover design (Figure 1). Patients were randomly
allocated using permuted blocks of 6 to an early or late intervention group by an independent person who was otherwise not
involved in the study. Allocation was concealed, using opaque sealed envelopes. The early intervention group
received cueing training for a period of 3 weeks immediately after randomization. The training program consisted of 9
sessions of 30 minutes over 3 weeks and was immediately followed by a control period of 3 weeks. Patients were
encouraged to practice on their own after each training session. At each visit the therapist checked the use of the cueing
device outside training time. The late intervention group was put on a waiting list for the first 3 weeks and subsequently
received the same cueing program in the second 3 weeks. The choice of 9 treatment sessions of 30 minutes each given in 3
weeks was pragmatically chosen based on the existing policies for reimbursement of physical therapy sessions at home at
the time of the study. The early intervention group had a follow-up period of 9 weeks, and the late training group had a
follow-up period of 6 weeks. Medication treatment stayed stable throughout the study. Prior to the trial all RESCUE
therapists and assessors participated in joint training sessions to standardize their treatment and assessment procedures.
Each country had 1 therapist and 1 assessor.
Figure 1. Cross-over design of the RESCUE trial. R, time of randomisation; Early, early intervention group; Late, late intervention
group;T1-T4, times1-4 of assessments with monitoring at 0, 3, 6 and 12 weeks.
Intervention
Each participant received cueing training in the home situation with the help of a prototype cueing device. This cueing device
was specifically developed for this project and provided 3 rhythmical cueing modalities: (a) an auditory modality (a beep), (b) a
visual modality (a flashing light at the side of the spectacles), and (c) a somatosensory modality (a miniature vibrating cylinder
on the wrist).8 Patients tried out every modality during the first week and practiced with their preferred cueing modality in the
second 2 weeks. In addition to the cueing device, parallel lines on the floor or pavement were used in the training as visual
cues. Cueing training was aimed at improving gait and gait-related activities (such as step length, walking speed, and
management of freezing).
Based on previous experiments undertaken by the RESCUE consortium14,16-18 and the literature,9,10 evidence-based guidelines were
drawn up, specifying the cueing parameters and instructions for different profiles of patients (available on CD-ROM,
http://www.rescueproject.org). Patients were instructed to use the cues and encouraged to practice without the assistance of the
therapist outside the regular training time.
Outcome Measures
In addition to recording time, the following outcomes were analyzed:
1. The percentage of time spent in walking, transfer, turning, stair climbing, and cycling activities (“dynamic
activities”), with percentage of time spent on walking alone (% walking), further specified as (a) average number of
walking periods registered per hour exceeding 5 seconds (W>5s)
and (b) average number of walking periods regis-
tered per hour exceeding 10 seconds (W>10s).
2. The percentage of time spent in standing, sitting, and lying postures (“static activities”).
The primary outcome measure was percentage of time spent on walking activity assuming 10% change in favor of cueing
therapy.
Assessment Protocol
All patients were tested by an assessor in their home environment prior to randomization (t1) and at 3 (t2), 6 (t3), and 12 weeks
(t4). Time points for follow-up (t3 and t4) were kept identical between early and late intervention for practical reasons. The
assessor was blind to group allocation. Each patient was visited at approximately the same time of the day in the on-
phase, about 1 hour after medication intake, to control for variations due to the medication cycle. A test battery was used
to assess gait and gait-related activities of the patient (for results, see Nieuwboer et al8). In addition, an AM (Yitaport3,
TEMEC Instruments BY, Kerkrade, The Netherlands) was applied by the assessor to record the body movements of the
subject during the day. To measure the effects of practice with cueing and not the immediate effects during cueing, the
cueing device was not used during monitoring. Moreover, training was not received on testing days.
The activity monitor consisted of a montage of 5 accelerometers connected to a portable data recorder worn on a belt
around the waist. The accelerometers were attached to the body as follows: one on each leg positioned on the lateral
aspect of the thigh midway between the greater trochanter of the femur and the midpoint of the patella, orientated in the
sagittal plane; 3 accelerometers were placed on the lower third of the sternum, with the sensors on a specially designed
block positioned so that they were orientated in the sagittal, longitudinal, and transverse planes. The skin was prepared by
cleaning the area with an alcohol swab and shaving when necessary. The accelerometers were mounted on a piece of thin
foam and attached to the skin using Hypafix® tape (BSN Medical, Charlotte, NC). Each accelerometer was connected to
a portable battery-powered activity monitor (Yitaport 3, TEMEC Instruments) by cables that ran under the clothes.
Data were sampled at a frequency of 256 Hz and stored at 32 Hz on a removable flash memory card for off-line
analysis. The accelerometers recorded gravitational force and accelerations of the moving lower limbs and trunk. The
data were analyzed using a specifically designed software program (Yitagraph; TEMEC Instruments Inc), which classified
activity into static activity (ie, sitting and standing) and dynamic activity (amount of walking and walking
Table 1. Comparison Between Early and Late Intervention Groups for Demography, Characteristics of Pa rkinson’s Disease, Clinical
Data, and Data Derived From Activity Monitoring at Baseline
Early Intervention Group
(n= 76), Median (Q 1 -Q3)
Late Intervention Group
(n= 77), Median (Q 1 -Q3) P Value
Demography
Gender (male/female)a 48/28 40/37 .16
Age (years) 67.5 (61.5-72) 69 (62.5-73) .70
PD characteristics
Disease duration (years) 7 (4-11) 8 (4-12) .59
H&Y (on) 2.5 (2.5-3) 3 (2.5-3) .56
Freezers/nonfreezersa 3 1/45 32/45 .92
Clinical data
UPDRS total 54 (46-65.5) 56 (49-63) .62
UPDRS motor scale 31 (25-37) 34 (28-41) .32
Levodopa (mg) 500 (300-700) 350 (200-550) .07
Data derived from AM
Registration time (hours) 4.9 (3.5-5.8) 4.56 (3.7-5.5) .17
Percentage of time spent on dynamic activity 9.4 (5.2-16.7) 10.6 (4.8-16.3) .74
Percentage of time spent on static activity 90.6 (81.8-94.8) 89.1 (83.7-95.2) .55
Percentage of time spent on sitting 50.3 (38.6-65.6) 49.2 (35.5-63.6) .49
Percentage of time spent on standing 25.0 (15.5-36.0) 25.8 (16.0-32.6) .69
Percentage of time spent on walking 7.3 (4.0-10.9) 7.9 (4.2-13.6) .55
N walking period >5 seconds per hour 13.7 (7.9-21.5) 13.5 (8.6-18.9) .65
N walking periods >10 seconds per hour 8.6 (4.4-13.0) 8.0 (5.2-12.0) .93
Abbreviations: Q 1 -Q3, interquartile range; PD, Parkinson’s disease; M/F, male and female; H&Y (on), Hoehn and Yahr during on; UPDRS,
Unified Parkinson’s Disease Rating Scale; AM, activity monitoring; N, number.
Source: Adapted from Nieuwboer et al.8
aExpressed as number of patients, and P values based on Mann–Whitney U tests.
periods exceeding 5 seconds and 10 seconds). The patient was not told about the specific function of the apparatus until
after the study and was specifically instructed to maintain their usual daily activities.
Analysis
AM data were initially processed using Vitagraph (TEMEC Instruments Inc). Data were analyzed using SPSS (SPSS Inc, Chicago,
IL). For ordinal scaled outcomes, nonparametric tests were used for data comparison between the early intervention group and the
late intervention group (ie, Mann–Whitney U test) at baseline. For dichotomous and normally distributed data, Fisher exact tests
and unpaired t tests were used, respectively. The level of significance was set 2 sided at P= .05.
Intervention effects were estimated using the first 3 assessments (t1, t2, and t3). Random coefficient analysis was used assuming a
normal distribution to evaluate the effects of intervention on % static activity, % dynamic activity, % standing, % sitting, %
walking, W>5s, and W>10s (MLWinN version 2.02).19 When the outcome variable failed to show a normal distribution on visual
inspection, a logarithmic or square root transformation was applied. In this multilevel model, effects of intervention were
corrected for differences of the outcome variable at baseline, time effects, and carryover effects. In addition, possible interaction
effects between intervention and time were investigated for significance.19 Change at follow-up was assessed by comparing the
change between t3 and t4 using a model with 2 factors (time and group) fitted onto outcomes of t1, t2, t3, and t4 for distribution, for
early and late intervention groups. Two-tailed analysis was performed on all tests with a significance level of 5%. Intervention effects
are reported as b estimates. Effect sizes were computed, using Cohen’s d, for t1-t2. The difference in length of follow-up was
addressed by separate testing of the decrements for late (t3-t4) and early intervention (t2-t4) using a paired t test.
Data from t1 and t2 of the late intervention group were used to investigate the reliability of AM. ICCs, using a 2-way
mixed model with an absolute agreement definition, were employed to calculate reliability of % static and % dynamic
activity.20 According to the recommendations of Fleiss,21 ICC values less than .40 represent poor reliability, values between .40
and .75 moderate to good reliability, and values more than .70 represent excellent reliability. Agreement was further analyzed
using the Bland and Altman22 method; the “limits of agreement,” defined as ±1.96 × standard deviation of the difference
scores, were computed.
Results
Out of 289 potential candidates, 153 patients participated in
the present study. A trial flow chart is presented in Nieuwboer
Table 2. Medians and Interquartile Ranges of the Outcomes in the Early and Late Intervention Groups at Tests 1 to 4
Test 1, Median
(Q1-Q3)
Test 2, Median
(Q1-Q3)
Test 3, Median
(Q1-Q3)
Test 4, Median
(Q1-Q3)
Registration time (hours)
Early 4.9 (3.5-5.8) 4.6 (3.6-5.6) 4.8 (3.6-5.5) 4.5 (3.4-5.7)
Late 4.6 (3.7-5.5) 4.7 (3.7-5.8) 4.8 (3.6-5.5) 4.9 (3.5-5.5)
Percentage of time spent on dynamic activitya
Early 9.4 (5.2-16.7) 13.7 (7.3-22.7) 11.7 (6.4-21.3) 9.6 (5.5-15.4)
Late 10.6 (4.8-16.3) 9.6 (5.8-18.9) 15.1 (7.4-22.8) 11.3 (6.6-20.5)
Percentage of time spent on static activitya
Early 90.6 (81.8-94.8) 86.3 (76.9-92.7) 88.3 (77.9-93.6) 90.3 (83.5-94.5)
Late 89.1 (83.7-95.2) 89.8 (80.6-94.2) 84.0 (73.9-92.4) 88.7 (79.4-93.4)
Percentage of time spent on sittinga
Early 50.3 (38.6-65.6) 40.8 (32.2-59.3) 46.8 (33.7-60.7) 49.6 (34.2-59.5)
Late 49.2 (35.5-63.6) 48.7 (34.5-59.4) 45.9 (35.5-57.4) 48.8 (34.2-65.3)
Percentage of time spent on standinga
Early 25.0 (15.5-36.0) 25.8 (19.1-37.8) 24.3 (17.6-35.7) 25.3 (16.0-38.7)
Late 25.8 (16.0-32.6) 28.7 (17.4-39.2) 23.5 (16.2-32.1) 25.6 (19.0-38.0)
Percentage of time spent on walkinga
Early 7.3 (4.0-10.9) 10.4 (6.0-18.7) 8.5 (4.8-13.0) 6.6 (4.1-11.7)
Late 7.9 (4.2-13.6) 7.6 (3.4-12.9) 11.8 (5.9-18.5) 7.9 (4.5-15.0)
N walking periods >5 seconds per hour
Early 13.7 (7.9-21.5) 15.1 (11.1-24.2) 15.3 (9.4-23.7) 14.1 (10.0-20.3)
Late 13.5 (8.6-18.9) 14.9 (8.3-20.3) 15.7 (9.6-26.1) 14.8 (10.1-22.6)
N walking periods >10 seconds per hour
Early 8.6 (4.3-13.0) 9.6 (5.9-14.5) 8.8 (5.5-14.7) 7.8 (5.4-12.0)
Late 8.0 (5.2-12.0) 8. 5 (4.2-12.2) 9.8 (6.2-17.1) 8.1 (5.6-14.9)
Abbreviations: Q 1-Q3, interquartile range; N, number. aPercentage of time spent of total registration time.
et al.8 Participants were randomly allocated to the early intervention group (n = 76) or late intervention group (n = 77).
Both groups showed comparable baseline characteristics (see Table 1, adapted from Nieuwboer et al8) confirming the success
of the randomization procedure.
As all patients received training, with only 1 dropout occurring 3 weeks after randomization because of a necessary
change of medication, an “intention-to-treat” analysis was not necessary. Patients did not report any falls or other problems
while wearing the activity monitors. In total, 556 of all 612 AM datasets, representing collected data of actual intended 4
repeated measurements within 153 included patients, were available for random coefficient modeling. All AM data
showed a normal distribution on visual inspection.
Table 2 shows the median and interquartile ranges of all outcomes at tests 1 to 4. Average recording time was 4.6 hours (median
4.8 hours) and did not differ between testing days (P > .9). The mean amount of therapy received in the early intervention
group (271.8 minutes) was not significantly different from the late intervention group (270.4 minutes; t = .27; P = .79).
Most patients (n = 95, 67%) chose auditory cueing as their preferred cueing modality, whereas the other patients (n =58,
33%) favored somatosensory cueing.
Treatment Effects
Tables 2 and 3 show the results for each assessment and the estimated intervention effects corrected for time and
carryover; correction for interaction effects was not necessary. The % dynamic activity improved from 9.4 to 13.7 (median)
in the early intervention group and from 9.6 to 15.1 in the late intervention group (b = 4.25; P < .01); an equal decrement
in static activity was shown. No significant effect was shown for % sitting and % standing. The % walking increased from
7.3 to 10.4 in the early intervention group and from 7.6 to 11.8 in the late intervention group (b = 4.2; P < .01). Periods
of W>5s increased from 13.7 to 15.1 times per hour (median) in the early intervention group and from 14.9 to 15.7 times
per hour in the late intervention group (b = 2.6; P < .01) after cueing training, and periods of W>10s increased from 8.6 to
9.6 times per hour in the early intervention group and from 8.5 to 9.8 times per hour in the late intervention group (b= 2.9;
P < .00 1) after the intervention phase. Effect sizes ranged from small for % sitting ( -0.14) and % standing ( -0.14) to
medium for % static activity ( -0.25), W>5s (0.26), % dynamic (0.33), and W>10s (0.35) to large for % walking (0.43;
Table 3).
Table 3. Intervention Effects for t1-t2 (Early Intervention Group) and t2-t3 (Late Intervention Group) Combined, Effect Size for t1-
t2, and Percentage of Change at Follow-up (Difference t3-t4 Intervention Groups Separately)
Intervention b
Estimate (SE)
Effect Size
(Cohen’s d),
for t1-t2
Change in
Minutes
Follow-up b
Estimate (SE)
Percentage of
Change t2-t4, Early
Intervention Group
Percentage of
Change t3-t4, Late
Intervention Group
Percentage of time spent
on dynamic activitya
4.46b .33 12.6 -4.17b -12.5c -17.3b
Percentage of time spent
on static activitya
-3.34b -.25 9.4 4.69b 1.8 5.0b
Percentage of time
spent on sittinga
-3.48 - . 14 9.8 4.20c 3.2 7.9c
Percentage of time
spent on standinga
-1.41 - . 14 4.0 -0.98 - 5 . 5 1.7
Percentage of time
spent on walkinga
4.23b .43 11.9 -3.57b - 9 . 9 -27b
N walking periods >5
seconds per hour
2.63c .26 2.6 N -3.32b - 6 . 4 -6.3b
N walking periods >10
seconds per hour
2.90b .35 2.9 N -2.68b - 6 . 9 -20b
Abbreviations: SE, standard error; N, number.
aPercentage of time spent of total registration time.
bP < .01.
cP < .05.
Follow-up (Early t2-t4, Late t3-t4)
Tables 2 and 3 also show the changes at follow-up. All intervention effects declined between 6 and 9 weeks. The % dynamic
activity was significantly reduced (from 13.7 to 11.7 in the early intervention group (t2-t4) and from 15.1 to 11.3 in the late
intervention group (t3-t4; b = 4.2; P < .001), and the % static activity increased from 86.3 to 90.3 in the early intervention
group and from 84.0 to 88.7 in the late intervention group ( b = 4.7; P < .001). The % sitting increased significantly (b =
4.2; P = .02) from 40.8 to 49.6 in the early intervention group and from 45.9 to 48.8 in the late intervention group; the %
standing did not change significantly. The % walking ( b = 3.6; P < .001), W >5s ( b = 3.3; P < .001), and W >10s ( b = 2.7;
P < .001) decreased as well. When separating the early and late intervention groups, significant decrements
between t2 and t4 were shown for percentage of dynamic activity (from 13.7 to 11.7; P < .001), walking (from 10.4 to
8.5; P < .001), and W>10s (from 9.6 to 8.8; P = .02), and an increment was shown for percentage of static activity (from
86.3 to 88.3; P = .001) for the early intervention group. No significant changes were found for percentage of sitting,
percentage of standing, and W>5s. For the late intervention group, significant decrements between t3 and t4 were shown
for percentage of dynamic activity (from 15.1 to 11.3; P < .001), percentage of walking (from 11.8 to 7.9; P < .001),
W >5s (from 15.7 to 14.8; P = .004), and W >10s (from 9.8 to 8.1; P < .001) and an increment for percentage of static
activity (from 84.0 to 88.7; P< .001). No significant changes were found for percentage of sitting and percentage of standing.
Monitoring proved to be reliable over a 3-week interval as can be seen in Table 4. Figure 2 additionally shows the Bland
and Altman22 plots for the different outcome measurements with the upper and lower dashed lines for 95% limits of
agreement and the bold line representing the mean difference score between 2 assessments. The visual plots showed sufficient
agreement between 2 consecutive measurements for the different outcomes of AM.
Discussion
The present study was aimed at investigating the effects of cueing training on the amount of physical activity in patients
with PD, when monitored in their own home environment.
The present study showed that cueing therapy has a significant positive effect on dynamic activity, especially on the
amount of walking activity from 9.4% to 13.7% of the total recorded time for the early intervention group and from 9.6%
to 15.1% for the late intervention group. When extrapolating the increased walking performance to a whole day of 12 waking
hours, the present finding suggests an increased amount of walking activity of 35 minutes per day. This amount meets the
criterion of 30 minutes of recommended physical activity per day by the Centers for Disease Control and Prevention/American
College of Sports Medicine.23 Encouraging patients to walk daily, together with a strict medication schedule, is highly
recommended in the treatment of gait disturbances in the early stages of PD.24 In a recent review, it was suggested that
exercise may be beneficial with regard to physical functioning, health-related quality of life, strength, balance, and gait
speed in patients
Figure 2. Repeated measures without intervention (t1-t2) for the control phase of the late intervention group. Agreement of six outcome
measurements following Bland Altman plots. Dashed bold lines represent the mean difference scores, dashed lines represent limits of
agreement, defined as the mean ±1.96 × standard deviation of the difference score.
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with PD.25 Indeed, the present findings are in line with the results from clinical assessments in the RESCUE trial.8 Briefly,
clinical assessments showed a 4.2% increase on the posture and gait score, a 5.0 cm/s increase in walking speed, a 4.0 cm
increase in step length, and a 5.5% reduction in severity of freezing symptoms according to the Freezing of Gait
Questionnaire when analyzed in freezers only.8 The agreement in effects between AM and clinical gait assessments
suggests that improvements in clinically used outcomes such as posture and gait score, step length, and gait speed
reflect a general enhancement in patients’ actual walking performance. A major advantage of AM is that patients do not
have to undergo a fatiguing test battery, and
more detailed information about the actual activity profile is achieved.26 The relatively small effects in favor of rhythmic
cueing are comparable with found effects in gait-related outcomes after meta-analysis of studies on exercise therapy in PD.27
These effects are also in line with found effects of exercise therapy in stroke rehabilitation showing favorable effects of exercise
therapy ranging from 5% to 1 0%.28 Improvements in activity were reduced at follow-up, assessed 9 weeks after the
end of cueing training for the early intervention group and 6 weeks for the late intervention group. The reductions were
approximately the same for both groups, suggesting that the effect of intervention largely wears off in the first 6 weeks.
Continuous training
Table 4. Intraclass Correlation Coefficients, 2-Way Mixed Model With Absolute Agreement Definition
Variable ICC (95% CI)
Registration time .68 (.53-.78)
Dynamic activity .81 (.71-.87)
Static activity .76 (.65-84)
Sitting .59 (.42-.72)
Standing .50 (.31-65)
Walking .72 (.58-.81)
Walking periods exceeding 5 seconds .68 (.53-.78)
Walking periods exceeding 10 seconds .73 (.60-.82)
Abbreviations: ICC, intraclass correlation coefficients; CI, confidence interval.
with use of a permanent cueing device may therefore be indicated for people with PD. The optimal dose–response
relationship needs to be investigated in future studies. The pragmatic selected dose of 9 treatments of physical therapy may be
an insufficient dose of therapy to have introduced longterm effects. Thus, further studies are needed to investigate the optimal dose–
response relationship in patients with PD. The impact of placebo effects as a result of increased attention during therapy
was not controlled for, which is a limitation of this study.
In line with a previous study,11 AM proved to be a reliable method for monitoring gait performance with fair to good
reliability (ICC = .50-.72) for registration time, static activities, sitting and standing and excellent reliability (ICC = .76-.81)
for dynamic activity, W>5s and W>10s. In addition, Bland Altman plots22 showed good to excellent agreement between 2
consecutive AM measurements with respect to the different static and dynamic activities of AM.
AM may cause so-called reactivity effects: subjects may, consciously or subconsciously, limit their movements due to the
presence of the recorder, its weight, and the wiring or because they are afraid to break or damage the monitoring equipment. On
the other hand, subjects may be more active to “make the measurement better” and meet the expectations of the research
goal. Therefore, it is important to prevent AM-induced behavioral adaptations by keeping the participants naive about the
purpose of the AM device and giving appropriate instructions about maintaining usual daily routines.
A limitation of the AM device used in the present study is that the accelerometers do not produce valid information about
spatial parameters of gait such as step length and walking distance and with that speed. In particular, it is difficult to quantify
parameters such as step length in patients with PD where the variability in step-to-step length is large.29,30 Lack of insight
into patients’ on–off status is another limitation in this study. It is, for example, not known whether patients walked more during
their off periods after receiving cueing training. This may be addressed by asking patients to record their on–off status in a
diary while undertaking AM to provide complementary data. Future studies should focus on gait parameters including
walking speed, step length, and interlimb coordination of parkinsonian gait during “on” and “off” periods. In addition, efforts
should be made to develop smaller and cheaper AM devices that are wireless enabled and better able to monitor
continuously for more than 48 hours.
The application of AM in patients with neurological disorders such as PD to evaluate the effects of a rehabilitation program is
new in the field of neurology. However, it should be noted that AM can also be used for evaluating other interventions such
as medication31 and deep brain stimulation on motor performance. Moreover, AM proved to be a harmless, noninvasive way
of collecting “real-world” information about postures and activity undertaken in patients’ own environment for extended
periods of time.
Data from the current study further support the positive effects of cueing in PD as found in earlier studies8,10; however, the
neurological mechanisms underpinning these effects are still unclear. Studies suggest that cueing may stimulate
alternative cortical pathways (eg, visual motor pathways)32 to bypass the basal ganglia, whereas other studies suggest that
cueing synchronizes the simultaneous timing of interlimb coordination in the cerebellum needed for normal gait.33,34
Further studies are needed to investigate the neurophysiological mechanisms underpinning the effectiveness of rhythmic
cueing in patients with PD.
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